Kari Chansky

26.9k citations
80 papers · 17.3k · 8 hit papers · h-index 46

Impact in

    • Lung Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Inflammatory Biomarkers in Disease Prognosis

Papers in

    • Lung Cancer Diagnosis and Treatment 37
    • Lung Cancer Treatments and Mutations 13
    • Occupational and environmental lung diseases 5
    • Lung Cancer Research Studies 17
    • Colorectal Cancer Treatments and Studies 3
    • Cancer survivorship and care 2

Kari Chansky

77 papers receiving 16.8k citations

Kari Chansky's Hit Papers

The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer 2017 · 389 citations
3890+6+12Years since publication1k2k3k

Peers

Kari Chansky
Comparison fields: 5 of 117
  • Pulmonary and Respiratory Medicine 12.2k
  • Oncology 3.9k
  • Cancer Research 769
  • Radiology, Nuclear Medicine and Imaging 587
  • Otorhinolaryngology 132
Replace Masahiro Tsuboi with:
Masahiro Tsuboi Japan
Sang-We Kim South Korea
Wilfried Eberhardt Germany
Maurice Pérol France
Tuncay Göksel Türkiye
Giuseppe Procopio Italy
Tommaso Martino De Pas Italy
Katsuyuki Hotta Japan
Maximilian Johannes Hochmair Austria
Narikazu Boku Japan
Kari Chansky relative to Masahiro Tsuboi Japan Masahiro Tsuboi's profile →
Citations per field
00.5×1.5×
Masahiro Tsuboi · 1×
Citations per year

Countries citing papers authored by Kari Chansky

Since Specialization
Citations

This map shows the geographic impact of Kari Chansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Chansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Chansky more than expected).

Fields of papers citing papers by Kari Chansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Chansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Chansky. The network helps show where Kari Chansky may publish in the future.

Co-authors

The 25 scholars most cited alongside Kari Chansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kari Chansky Line = papers co-authored together Kari Chansky links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Hit paper breakdown →
20163544
2
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
Hit paper breakdown →
20073167
3
The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer
Hit paper breakdown →
20071399
4
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
Hit paper breakdown →
2016597
5
The International Association for the Study of Lung Cancer Lung Cancer Staging Project
Hit paper breakdown →
2015531
6
Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023
Hit paper breakdown →
2008473
7 2009428
8 2007417
9
The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer
Hit paper breakdown →
2009394
10
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer
Hit paper breakdown →
2017389
11 2009388
12 2015335
13 2003298
14 2014297
15 2008292
16 2007241
17 2008238
18 2008217
19 2016216
20 2016198

About Kari Chansky

Kari Chansky is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Statistics and Probability, Pathology and Forensic Medicine and Epidemiology, having authored 80 papers that have together received 17.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (37 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Treatments and Mutations (13 papers), Occupational and environmental lung diseases (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer survivorship and care (2 papers), Esophageal Cancer Research and Treatment (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (12.2k citations), Oncology (3.9k citations), Cancer Research (769 citations), Radiology, Nuclear Medicine and Imaging (587 citations) and Otorhinolaryngology (132 citations). Kari Chansky has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include John J. Crowley, Peter Goldstraw, Pieter E. Postmus, Ramón Rami–Porta, Valerie W. Rusch, Dorothy J. Giroux, Leslie H. Sobin, Patti A. Groome, David R. Gandara and Elisabeth M. Brambilla. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Investigational New Drugs, Clinical Cancer Research and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact